Clemens Scheinecker

Medical University of Vienna — Austria

Immunology and Microbiology · Life Sciences

40h-index7.2kcitations100works4.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

T-cell and B-cell Immunology(35), Systemic Lupus Erythematosus Research(23), Immune Cell Function and Interaction(23), Immunotherapy and Immune Responses(21), Rheumatoid Arthritis Research and Therapies(15)

Publications100 total

Humoral and cellular response to the third COVID-19 vaccination in patients with inborn errors of immunity or mannose-binding lectin deficiency
Wiener klinische Wochenschrift·2024· 4 citedOpen Access
Editorial
Journal für Mineralstoffwechsel & Muskuloskelettale Erkrankungen·2022Open Access
Reactogenicity and immunogenicity of the second COVID-19 vaccination in patients with inborn errors of immunity or mannan-binding lectin deficiency
Frontiers in Immunology·2022· 12 citedOpen Access
Rheumatoid Arthritis
2021
Editorial
Journal für Mineralstoffwechsel & Muskuloskelettale Erkrankungen·2021Open Access
Clemens von Pirquet
Annals of the Rheumatic Diseases·2021· 3 cited
Editorial
Journal für Mineralstoffwechsel & Muskuloskelettale Erkrankungen·2020Open Access
Histone deacetylase 1 (HDAC1): A key player of T cell-mediated arthritis
Journal of Autoimmunity·2019· 52 cited
Treg cells in health and autoimmune diseases: New insights from single cell analysis
Journal of Autoimmunity·2019· 212 cited
Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial
The Lancet·2019· 208 cited
Diagnostik und Therapie bei primären Immundefekten/„inborn errors of immunity“
Wiener klinische Wochenschrift Education·2019Open Access
Unreported Missense Mutation in the Dimerization Domain of ADA2 Leads to ADA2 Deficiency Associated with Severe Oral Ulcers and Neutropenia in a Female Somalian Patient—Addendum to the Genotype-Phenotype Puzzle
Journal of Clinical Immunology·2019· 10 cited
OP0194 HISTONE DEACETYLASE 1 (HDAC1): A KEY MEDIATOR OF T CELLS FOR THE PATHOGENESIS OF RHEUMATOID ARTHRITIS
Annals of the Rheumatic Diseases·2019Open Access
Treg cells in autoimmunity: from identification to Treg-based therapies
Seminars in Immunopathology·2019· 206 cited
P062 Histone deacetylase 1 (HDAC1): a novel therapeutic target in rheumatoid arthritis
Annals of the Rheumatic Diseases·2019Open Access
Peripheral nerve transfers change target muscle structure and function
Science Advances·2019· 73 citedOpen Access
CCR6 controls autoimmune but not innate immunity‐driven experimental arthritis
Journal of Cellular and Molecular Medicine·2018· 12 citedOpen Access
THU0084 Histone deacetylase 1 (HDAC1): a novel therapeutic target in patients with rheumatoid arthritis
Annals of the Rheumatic Diseases·2018Open Access
P116 Histone deacetylase 1: a novel therapeutic target for patients with rheumatoid arthritis
Annals of the Rheumatic Diseases·2018· 1 citedOpen Access
How does abatacept really work in rheumatoid arthritis?
Current Opinion in Rheumatology·2018· 64 cited
page 1 of 5Next →

Frequent Co-authors

Michael Bonelli(17), Josef S Smolen(13), Otto Majdic(12), Walter Knapp(12), Herbert Strobl(12), Winfried F. Pickl(9), Josef S Smolen(9), Lisa Göschl(9), Elisabeth Riedl(7), Stephan Blüml(6), G Steiner(6), Johannes Stöckl(5), Thomas Karonitsch(5), C Bello-Fernández(4), Kurt Redlich(4), Ruth A. Byrne(4), Birgit Niederreiter(4), Karin Polzer(3), Georg Schett(3), K Dalwigk(3)